It’s Better to Hope for Prosperity than Become Adversary: AnaptysBio Inc (ANAB) Stock
Leerink Partners raised the price target for the AnaptysBio Inc (NASDAQ:ANAB) stock to “an Outperform”. The rating was released on April 16, 2024, according to finviz. The research report from Wedbush has upgraded the stock from Neutral to Outperform, with a price target set at $34. The stock was initiated by BTIG Research, who disclosed […]
